Table 1 MicroRNA precursors encoded in host genes with fusion transcripts in our data and in TCGA data
From: Frequent miRNA-convergent fusion gene events in breast cancer
Any fusion | 5′ Fusion partner | 3′ Fusion partner | |
|---|---|---|---|
≥ 1 Tumor | 802 (61%) | 691 (52%) | 640 (48%) |
≥ 1 Tumor and in TCGA | 163 (12%) | 155 (12%) | 153 (12%) |
≥ 1 Tumor and in TCGA breast | 142 (11%) | 66 (5%) | 80 (6%) |
Recurrent (≥ 3 tumors) | 514 (39%) | 426 (32%) | 380 (29%) |
Recurrent and in TCGA | 124 (9%) | 119 (9%) | 92 (7%) |
Recurrent and in TCGA breast | 101 (8%) | 51 (4%) | 47 (4%) |
Recurrent our data and TCGA | 44 (3%) | 24 (2%) | 18 (1%) |
Recurrent our data and TCGA breast | 14 (1%) | 8 (1%) | 6 (0.5%) |
